Global Oxygen Therapy Equipment Market is Predicted to Surge at ~8% CAGR by 2032 Owing to the Rising Respiratory Disorders and Technological Advancements | DelveInsight

The global oxygen therapy equipment market is experiencing robust growth, driven by the rising prevalence of respiratory disorders, increased utilization in critical care settings, and rapid technological advancements. The growing prevalence of COPD, asthma, and other chronic lung diseases has amplified the need for continuous oxygen support in both hospital and home care environments. In intensive care settings, oxygen devices play a vital role in managing patients with severe respiratory or cardiac conditions. Meanwhile, advancements such as AI-enabled concentrators, real-time monitoring systems, and compact, portable designs are enhancing treatment accuracy and user convenience. Collectively, these developments are accelerating adoption and reinforcing the market’s upward momentum.

New York, USA, Nov. 06, 2025 (GLOBE NEWSWIRE) — Global Oxygen Therapy Equipment Market is Predicted to Surge at ~8% CAGR by 2032 Owing to the Rising Respiratory Disorders and Technological Advancements | DelveInsight

The global oxygen therapy equipment market is experiencing robust growth, driven by the rising prevalence of respiratory disorders, increased utilization in critical care settings, and rapid technological advancements. The growing prevalence of COPD, asthma, and other chronic lung diseases has amplified the need for continuous oxygen support in both hospital and home care environments. In intensive care settings, oxygen devices play a vital role in managing patients with severe respiratory or cardiac conditions. Meanwhile, advancements such as AI-enabled concentrators, real-time monitoring systems, and compact, portable designs are enhancing treatment accuracy and user convenience. Collectively, these developments are accelerating adoption and reinforcing the market’s upward momentum.

DelveInsight’s Oxygen Therapy Equipment Market Insights report provides the current and forecast market analysis, individual leading oxygen therapy equipment companies’ market shares, challenges, oxygen therapy equipment market drivers, barriers, trends, and key oxygen therapy equipment companies in the market.

Oxygen Therapy Equipment Market Summary

• The global oxygen therapy equipment market size is expected to increase from ~USD 3 billion in 2024 to ~USD 6 billion by 2032, reflecting strong and sustained growth.
• The global oxygen therapy equipment market is expected to grow at a CAGR of ~8% during the forecast period from 2025 to 2032.
• The leading companies working in the oxygen therapy equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Drägerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited, and others.
• Among all the regions, North America is anticipated to register the fastest growth in the oxygen therapy equipment market during the forecast period. 
• Within the product type segment of the oxygen therapy equipment market, the system catheters category held the largest share in 2024.

To read more about the latest highlights related to the oxygen therapy equipment market, get a snapshot of the key highlights entailed in the Global Oxygen Therapy Equipment Market Forecast Report

Key Factors Contributing to the Rise in Growth of the Oxygen Therapy Equipment Market

Increase in the Cases of Respiratory Disorders

The rising incidence of chronic and acute respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and pneumonia, is a major factor fueling the growth of the oxygen therapy equipment market. The World Health Organization (WHO) identifies COPD as one of the leading global causes of illness and death, especially among older adults and populations exposed to severe air pollution. Increasing cases of respiratory insufficiency and hypoxemia are driving greater demand for oxygen concentrators, cylinders, and portable oxygen systems. Additionally, lifestyle-related factors like smoking, exposure to toxic industrial gases, and worsening urban air quality are escalating respiratory health issues, boosting the use of oxygen therapy in hospitals as well as home care environments. As the burden of respiratory diseases rises, healthcare providers are increasingly focusing on long-term oxygen support solutions, thereby accelerating market expansion.

Significant Usage in Critical Care

Oxygen therapy equipment is indispensable in critical care settings, where maintaining proper oxygen levels is crucial for patient survival and recovery. Hospitals and ICUs are increasingly adopting advanced oxygen delivery systems to treat patients experiencing severe respiratory distress, postoperative complications, or cardiac issues. The rising number of emergency cases caused by respiratory failure, trauma, and sepsis is boosting the demand for efficient stationary concentrators, ventilators, and oxygen delivery devices. Moreover, innovations in monitoring and integrated oxygen flow technologies allow healthcare professionals to administer accurate oxygen concentrations, enhancing treatment outcomes. As critical care infrastructure expands and the focus on advanced respiratory support grows, the global market for oxygen therapy equipment continues to gain momentum.

Rapid Technical Innovation in Product Development

Ongoing technological advancements are reshaping the oxygen therapy equipment market by enhancing portability, efficiency, and patient comfort. The latest oxygen concentrators incorporate compact designs, extended battery life, automated oxygen flow control, and smart connectivity for remote monitoring and management. The adoption of artificial intelligence (AI) and Internet of Things (IoT) solutions enables continuous tracking of oxygen consumption and patient health data, improving treatment compliance and clinical outcomes. Additionally, manufacturers are focusing on noise reduction, lightweight construction, and intuitive interfaces to elevate user experience, especially in home care environments. These developments are making oxygen therapy more accessible outside hospital settings, empowering patients to manage chronic respiratory conditions more independently. Consequently, rapid innovation is fueling greater market adoption and supporting sustained growth in the oxygen therapy equipment sector.

Get a sneak peek at the oxygen therapy equipment market dynamics @ Oxygen Therapy Equipment Market Trends

Regional Oxygen Therapy Equipment Market Insights

North America, led by the United States, holds a dominant position in the global oxygen therapy equipment market, accounting for nearly 42% of the total market share in 2024. The increasing incidence of chronic respiratory disorders primarily fuels this dominance. As per DelveInsight’s 2024 analysis, over 35.5 million Americans are affected by chronic lung diseases, including asthma and COPD. Within this group, about 11.5 million adults (4.6% of the U.S. adult population) have been diagnosed with COPD, encompassing both chronic bronchitis and emphysema.

Ongoing technological advancements, such as AI-enabled oxygen concentrators, real-time monitoring systems, and portable wearable devices, are transforming patient care by improving safety, compliance, and therapeutic outcomes. These innovations allow continuous oxygen level tracking, automatic oxygen flow regulation, and remote connectivity, ensuring consistent and efficient therapy while reducing the strain on healthcare systems.

In Europe, market growth is mainly driven by the increasing incidence of chronic illnesses, including cancer and cardiovascular diseases, which often require frequent oxygen therapy. The rising number of chemotherapy procedures and the growing use of oxygen devices among pediatric patients are further driving demand.

Meanwhile, the Asia-Pacific region is witnessing robust expansion, projected to grow at a CAGR of 9.27% between 2025 and 2032. This surge is attributed to the escalating prevalence of COPD, asthma, and other pulmonary conditions, coupled with a rapidly aging population requiring long-term oxygen support. India, China, and Japan are emerging as pivotal markets, with India expected to record the fastest growth rate in the coming years.

To know more about why North America is leading the market growth in the oxygen therapy equipment market, get a snapshot of the Oxygen Therapy Equipment Market Share

Recent Developmental Activities in the Oxygen Therapy Equipment Market

• In June 2025, Inogen, Inc., a prominent medical technology company specializing in advanced respiratory solutions for home care, unveiled the Voxi 5, a new stationary oxygen concentrator (SOC) designed to enhance access to high-quality oxygen therapy for long-term care patients in the United States. This latest addition to Inogen’s product lineup complements its range of portable oxygen concentrators, broadening market opportunities and capitalizing on the company’s established distribution and sales channels.
• In June 2025, VARON, a global respiratory care company, officially introduced a new platform specifically designed for the Mexican market, responding to the growing healthcare priority of providing reliable home oxygen therapy amid the rising prevalence of chronic respiratory conditions in the country.
• In January 2025, Caire announced the launch of its new IntenOxy 5 stationary oxygen concentrator. According to the company, the device is now available for purchase in the United States and Puerto Rico, with plans to expand availability to Canada in the near future.

What is Oxygen Therapy Equipment?

Oxygen therapy equipment plays a crucial role in managing respiratory conditions by delivering supplemental oxygen to patients with insufficient oxygen levels in their blood. This equipment includes oxygen concentrators, cylinders, liquid oxygen systems, and accessories such as masks, nasal cannulas, and regulators. Technological advancements have led to the development of compact, portable oxygen concentrators that enhance patient mobility and independence, allowing individuals to maintain an active lifestyle while receiving continuous therapy. These devices are widely used in hospitals, clinics, and home care settings for conditions such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19-related respiratory distress.

Oxygen Therapy Equipment Market Assessment

• Oxygen Therapy Equipment Market Segmentation
  • Oxygen Therapy Equipment Market Segmentation By Product Type: Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, and Others] and Disposables and Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, and Others]
  • Oxygen Therapy Equipment Market Segmentation By Portability: Stationary and Portable
  • Oxygen Therapy Equipment Market Segmentation By Application: COPD, Asthma, Respiratory Distress Syndrome, and Others
  • Oxygen Therapy Equipment Market Segmentation By End-User: Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others
  • Oxygen Therapy Equipment Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the oxygen therapy equipment market are set to emerge as the trendsetter explore @ Oxygen Therapy Equipment Market Analysis

Table of Contents 

Interested in knowing the oxygen therapy equipment market share by 2032? Click to get a snapshot of the Oxygen Therapy Equipment Market Size 

Related Reports

Chronic Obstructive Pulmonary Disease Treatment Devices Market

Chronic Obstructive Pulmonary Disease Treatment Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key COPD treatment devices companies, including Koninklijke Philips N.V., Omron Healthcare, Inc., Aerogen, GF Health Products, Inc., BMC Medical Co., Ltd., Medtronic, Trudell Medical International, Novartis AG, AstraZeneca, Lupin, Zydus Cadila, Teva Pharmaceutical Industries Ltd, Terumo Corporation, Cipla Inc., Microlife Corporation, Honsun, Promed Technology Co. Limited, HELTMAN Medikal A.S., Pneuma Respiratory, Lepu Medical Technology (Beijing) Co., Ltd., among others.

High Flow Oxygen Therapy Devices Market

High Flow Oxygen Therapy Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key high flow oxygen therapy devices companies, including Fisher & Paykel Healthcare, Masimo, Vapotherm, BMC Medical, ResMed, Allied Medical Limited, Hamilton Medical, Neotech Medical Systems Pvt. Ltd., Respircare, Ambulanc (Shenzhen) Tech. Co., Ltd., Intersurgical Ltd., Drägerwerk AG & Co. KGaA, MEKICS Co., Ltd., Peak Medical, Koninklijke Philips N.V., Hamilton Medical, GE Healthcare, Medtronic plc., Mindray, Nihon Kohden, Smiths Medical, among others.

Chronic Obstructive Pulmonary Disease Market

Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key COPD companies including Genentech, Inc., GlaxoSmithKline, Verona Pharma plc, Regeneron Pharmaceuticals, Sanofi, MedImmune LLC, EpiEndo Pharmaceuticals, Tetherex Pharmaceuticals, AstraZeneca, Chiesi Farmaceutici S.p.A., Synairgen Research Ltd., Mereo Biopharma, Organicell Regenerative Medicine, Pulmotect, Inc., Inmunotek S.L., PULMATRiX, GLENMARK PHARMACEUTICALS LTD, Dimerix Limited, ProterixBio, among others.

Asthma Market

Asthma Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key asthma companies including GlaxoSmithKline, 4D Pharma plc, AstraZeneca, Suzhou Connect Biopharmaceuticals, Avillion, Pearl Therapeutics, ARS Pharmaceuticals, Sinomab, Avalo Therapeutics, Kymab, Sanofi, Cumberland Pharmaceuticals, Genentech, Inc., among others.

Acute Respiratory Distress Syndrome Market

Acute Respiratory Distress Syndrome Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key ARDS companies, including MediciNova, Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals, Athersys, Healios, Direct Biologics, Biohaven Pharmaceutical, Arch Biopartners, APEPTICO Forschung und Entwicklung GmbH, Staidson (Beijing) Biopharmaceuticals, Veru, Mesoblast Limited, Avalo Therapeutics, Pluristem Therapeutics, ILTOO Pharma, among others.

DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.

Other Business Pharmaceutical Consulting Services

Healthcare Conference Coverage

Pipeline Assessment

Healthcare Licensing Services

Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

CONTACT: Contact Us

Shruti Thakur 

[email protected] 

+14699457679 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.